1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Infectious Disease Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Infectious Disease Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Infectious Disease Diagnostics Market Regional Analysis
6.2 Asia Pacific Infectious Disease Diagnostics Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Infectious Disease Diagnostics Market Forecast Analysis
7. Asia Pacific Infectious Disease Diagnostics Market Analysis – by Product
7.1 Kits & Reagents
- 7.1.1 Overview
- 7.1.2 Kits & Reagents: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Instruments: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Software & Services
- 7.3.1 Overview
- 7.3.2 Software & Services: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Asia Pacific Infectious Disease Diagnostics Market Analysis – by Technology
8.1 Biosensor-Based
- 8.1.1 Overview
- 8.1.2 Biosensor-Based: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Immunodiagnostics
- 8.2.1 Overview
- 8.2.2 Immunodiagnostics: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Molecular-Based Diagnostic Techniques
- 8.3.1 Overview
- 8.3.2 Molecular-Based Diagnostic Techniques: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Clinical Biology
- 8.4.1 Overview
- 8.4.2 Clinical Biology: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Asia Pacific Infectious Disease Diagnostics Market Analysis – by Application Type
9.1 Laboratory Testing and Point-of-Care Testing
- 9.1.1 Overview
- 9.1.2 Laboratory Testing and Point-of-Care Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Asia Pacific Infectious Disease Diagnostics Market Analysis – by Testing Type
10.1 Human Testing and Veterinary Testing
- 10.1.1 Overview
- 10.1.2 Human Testing and Veterinary Testing: Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Asia Pacific Infectious Disease Diagnostics Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Asia Pacific Infectious Disease Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.1.2 China: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.1.3 China: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.1.4 China: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.2 India:
Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.2.2 India: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.2.3 India: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.2.4 India: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.3 Japan:
Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.3.2 Japan: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.3.3 Japan: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.3.4 Japan: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.4 Australia:
Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.4.2 Australia: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.4.3 Australia: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.4.4 Australia: Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Testing Type
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Product
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Technology
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Application Type
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Infectious Disease Diagnostics Market Breakdown, by Testing Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 AccuBioTech Co Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 ACON Laboratories Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Bio-Rad Laboratories Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bruker Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Cardinal Health Inc
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Danaher Corp
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 DiaSorin SpA
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Trinity Biotech Plc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations